Adenosine receptors and epilepsy: current evidence and future potential

Area of Science:

• Neuroscience
• Pharmacology
• Epilepsy Research

Background:

• Adenosine acts as a homeostatic regulator in the brain, influencing the balance between neural excitation and inhibition.
• Adenosine receptors are recognized as a promising therapeutic target for managing epileptic seizures.
• The anticonvulsant properties of adenosine are well-documented, suggesting its therapeutic potential.

Purpose of the Study:

• To explore the role of adenosine receptors, specifically the A1 subtype, in regulating seizure activity.
• To investigate mechanisms that modulate adenosine levels as a strategy for influencing seizure propensity.
• To highlight the combined potential of adenosine-based therapies and novel targeting strategies for epilepsy.

Main Methods:

• Review of existing literature on adenosine receptors and epilepsy.
• Analysis of evidence implicating adenosine A1 receptor subtype in seizure regulation.
• Exploration of mechanisms affecting endogenous adenosine levels and their impact on receptor activity.

Main Results:

• Adenosine receptors, especially the A1 subtype, can powerfully and bidirectionally regulate seizure activity.
• Mechanisms regulating adenosine itself are emerging as viable targets to modulate receptor activity and epilepsy.
• Adenosine's role as a homeostatic neuromodulator is key to its anticonvulsant efficacy.

Conclusions:

• Adenosine receptors represent a significant therapeutic avenue for epilepsy treatment.
• Targeting adenosine receptor activity and endogenous adenosine mechanisms offers a dual approach to enhance anticonvulsant therapies.
• Leveraging adenosine's homeostatic neuromodulatory functions can lead to novel epilepsy treatments.